ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag nonprofit cancer business fda

FDA Gives Nod to Melanoma Drug
Jef Akst | Sep 8, 2014 | 2 min read
The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.
A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018 | 10+ min read
The scientific community said goodbye to a number of leading researchers this year.
FDA Reform Debate Heating Up As Senate, House Propose Bills
Karen Young Kreeger | May 12, 1996 | 10+ min read
House Propose Bills Companies, scientists, and patient-advocacy groups all applaud the ultimate objective of recently introduced legislation designed to get effective drugs to patients more quickly. However, not everyone agrees that the current versions of the Senate and House bills to reform the Food and Drug Administration are the way to accomplish the goal. DISSENTER: Edward Kennedy (D-Mass.) voted against the Senate bill. Proponents say the bills move reform in the right direction. Mean
Venture Capital, with a Twist
Ted Agres(tagres@the-scientist.com) | Jul 17, 2005 | 5 min read
Jamie Heywood, chief executive of the Amyotrophic Lateral Sclerosis Therapy Development Foundation (ALSTDF), founded the nonprofit biotech company in 1999 after his brother was diagnosed with ALS.
Imagining a Cure
Nicholas P. Restifo and Megan Bachinski | Apr 10, 2011 | 5 min read
For cancer patients, close is not good enough.
Banking on iPSCs
Kerry Grens | Jun 29, 2014 | 6 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Track Your Package
Amber Dance | Jun 1, 2011 | 7 min read
How to follow stem cells transplanted into living tissue.
The Goal: Control Blood Vessel Development
Harvey Black | Mar 17, 2002 | 7 min read
Managing blood vessel development by preventing its growth from tumors in cancer patients or stimulating its development in cardiac disease patients is apparently an idea whose time has come. William Li, president and medical director of the non-profit Angiogenesis Foundation in Boston, notes that using such control as a way to fight disease interpenetrates highly varied fields of medicine. "Angiogenesis is a common denominator in many of society's most significant medical conditions," says Li.

Run a Search

ADVERTISEMENT